Roche Holding (RHHBY.PK), in the middle of an expensive bid for Genentech (DNA), is in...


Roche Holding (RHHBY.PK), in the middle of an expensive bid for Genentech (DNA), is in preliminary talks to invest in or takeover Israeli microRNA-based diagnostics and therapeutics developer Rosetta Genomics (ROSG).

From other sites
Comments (1)
  • John Motyka
    , contributor
    Comments (69) | Send Message
     
    The only thing worth taking over is the lab test. Geez, what a mess; all the way down to this from $7 so long ago. Very disappointing...JDM
    13 Oct 2011, 02:25 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs